In comparison, patients with lower metabolic levels experience the appetite-suppressing effect of semaglutide for a longer time
Reviewing previous IBD treatment response: If a biologic or advanced IBD treatment has not worked as expected, it may be appropriate to review treatment history, disease activity, drug levels, antibodies, timing of response and whether symptoms are due to inflammation or an overlapping condition
Retatrutide at 12 mg weekly currently produces the largest weight loss of any published Phase 3 GLP-1-class compound, exceeding tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints
[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Mohd Yusof BN, Hasbullah FY, Mohd Shahar AS, et al
Safety and Side Effects While peptide therapy is generally considered safe, it is essential to work with a qualified healthcare provider to avoid potential side effects